Early research (Phase 1)Looking for participantsNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Early research (Phase 1)Study completedNCT00101270What this trial is testingOxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasWho this might be right forChildhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00020267What this trial is testingVaccine Therapy in Treating Patients With Metastatic CancerWho this might be right forLung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT07106827What this trial is testingGV20-0251 in Advanced or Refractory Solid TumorsWho this might be right forHCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more West China Hospital 10
Early research (Phase 1)Looking for participantsNCT04119024What this trial is testingGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more Anusha Kalbasi 18
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16
Early research (Phase 1)Ended earlyNCT04348916What this trial is testingStudy of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid TumorsWho this might be right forCancerMelanomaSolid Tumor+7 more Oncorus, Inc. 66
Very early researchActive Not RecruitingNCT06148636What this trial is testingA Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine TumorsWho this might be right forNeuroendocrine TumorsNeuroendocrine Tumor of the LungNeuroendocrine Tumor Grade 1+2 more David Bushnell 24
Early research (Phase 1)Study completedNCT00441337What this trial is testingMDX-1106 in Patients With Selected Refractory or Relapsed MalignanciesWho this might be right forCarcinoma, Non-Small-Cell LungColorectal CancerMalignant Melanoma+2 more Bristol-Myers Squibb 39
Early research (Phase 1)Study completedNCT01625351What this trial is testingCD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and LymphomasWho this might be right forEwing SarcomaGastrointestinal TumorGerm Cell Tumor+10 more St. Jude Children's Research Hospital 23
Early research (Phase 1)Study completedNCT01638533What this trial is testingRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionWho this might be right forGliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Looking for participantsNCT06265025What this trial is testingGM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsWho this might be right forHead and Neck CancerMalignant MelanomaColorectal Cancer+3 more GeneMedicine Co., Ltd. 125
Early research (Phase 1)UnknownNCT03634982What this trial is testingDose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid TumorsWho this might be right forSolid Tumors Revolution Medicines, Inc. 133
Early research (Phase 1)Study completedNCT02045368What this trial is testingStudy of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1RWho this might be right forBreast CancerBrain CancerGastrointestinal Cancers+5 more IGF Oncology, LLC 92
Early research (Phase 1)Ended earlyNCT01769222What this trial is testingIpilimumab and Local Radiation for Selected Solid TumorsWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more Stanford University 3
Early research (Phase 1)Looking for participantsNCT06910657What this trial is testingIDOV-Immune for Advanced Solid TumorsWho this might be right forColorectal CancerPancreatic CancerMelanoma+13 more ViroMissile, Inc. 78
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Not applicableAvailableNCT07262970What this trial is testingIntermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a TumorWho this might be right forTumor-associated Hyperinsulinism (Tumor HI) Rezolute
Testing effectiveness (Phase 2)Looking for participantsNCT06055439What this trial is testingEvaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell TherapyWho this might be right forNeuroendocrine TumorsColorectal CancerGastric Cancer Chimeric Therapeutics 135